Cysteine leukotrienes as key mediators of immune-dependent diseases and the therapeutic potential of the leukotriene receptor antagonist (montelukast). Part 2

N. G. Astafieva; I. E. Mikhailova; E. O. Gaisina; I. A. Perfilova; E. N. Udovichenko

Lechaschi Vrach
Lechaschi Vrach

ISSN 1560-5175 (Print)
ISSN 2687-1181 (Online)

User

eng | рус

Lechaschi Vrach

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Astafieva N.G., Mikhailova I.E., Gaisina E.O., Perfilova I.A., Udovichenko E.N. Cysteine leukotrienes as key mediators of immune-dependent diseases and the therapeutic potential of the leukotriene receptor antagonist (montelukast). Part 2. Lechaschi Vrach. 2024;(5):77-87. (In Russ.) https://doi.org/10.51793/OS.2024.27.5.013

Views PDF (Rus): 42

JATS XML

This work is licensed under a Attribution-NonCommercial-NoDerivatives 4.0 International.

ISSN 1560-5175 (Print)
ISSN 2687-1181 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

MANAGING EDITOR

E.O. Girutskaya

Popular articles

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

N. G. Astafieva
Federal State Budgetary Educational Institution of Higher Education Saratov State Medical University named after V. I. Razumovsky of the Ministry of Health of the Russian Federation
Россия

Natalia G. Astafieva, Dr. of Sci. (Med.), Professor, Head of the Department of Clinical Immunology and Allergology